Announcements Trials
Browse Landscape

Status

Recruiting 2Completed 2Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Plasma cell 1Gynecologic 1

Conditions

Postoperative Complications 1Ovarian Neoplasms 1Carcinoma, Ovarian Epithelial 1

Interventions

Paclitaxel 69Carboplatin 66Cisplatin 36pembrolizumab 34Gemcitabine 24liposomal doxorubicin 23Cyclophosphamide 23Topotecan 22Bevacizumab 20Taxes 14Docetaxel 13niraparib 12Nivolumab 12olaparib 10fludarabine 10Doxorubicin 9Surveys and Questionnaires 8Radiotherapy 8Oxaliplatin 8aldesleukin 7Filgrastim 7rucaparib 6oregovomab 6fludarabine phosphate 6durvalumab 6avelumab 6Interleukin-2 6Hyperthermic Intraperitoneal Chemotherapy 6Fluorodeoxyglucose F18 6Cytoreduction Surgical Procedures 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Geriatric Assessment × Gynecologic × Clear all
NCT01175967 2015-10-12

Use of Palliative Performance and Symptom Distress Scales in Older Patients With Advanced Ovarian Cancer

UNC Lineberger Comprehensive Cancer Center

Terminated
11 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Postoperative Complications

Data powered by HemOnc (CC BY 4.0) Colophon âš¡